Poxel SA
F:7PO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
Poxel SA
F:7PO
|
FR |
|
S
|
Sony Group Corp
F:SON1
|
JP |
|
S
|
Solargiga Energy Holdings Ltd
XMUN:3FV
|
HK |
|
ARMOUR Residential REIT Inc
F:2AR
|
US |
|
C
|
Calix Inc
F:CXA
|
US |
|
IntegraFin Holdings plc
OTC:IHPGF
|
UK |
|
Kagome Co Ltd
F:5EW
|
JP |
|
Laurentian Bank of Canada
TSX:LB
|
CA |
|
Upland Software Inc
NASDAQ:UPLD
|
US |
|
Parkway Corporate Ltd
F:4IP
|
AU |
|
Bosch Fren Sistemleri Sanayi ve Ticaret AS
IST:BFREN.E
|
TR |
|
M
|
Medibank Private Ltd
XMUN:MPV
|
AU |
|
C
|
Cogeco Communications Inc
F:COG
|
CA |
|
E
|
Eni SpA
SWB:ENI
|
IT |
|
H
|
Host Hotels and Resorts, Inc
F:HMT
|
US |
|
A
|
Ansell Ltd
DUS:PD1A
|
AU |
|
L
|
Lucara Diamond Corp
F:LKT
|
CA |
|
M
|
Melia Hotels International SA
XMUN:MEL
|
ES |
|
A
|
Avex Inc
F:AX8
|
JP |
Intrinsic Value
Is 7PO undervalued or overvalued?
See the intrinsic value estimate for 
Poxel SA and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
7PO looks undervalued.
But is it cheap by its own standards?
See how today’s valuation compares with 7PO’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Poxel Does
Poxel SA is a French biopharmaceutical company that focuses on drugs for metabolic diseases, especially type 2 diabetes and related liver disorders. It does not sell a broad range of medicines; instead, it develops a small number of drug candidates and works through partners to bring them to market. Its best-known program is imeglimin, a diabetes treatment that has been developed with commercial partners in Asia.
- Headquarters
- France FR
- Employees
- 5
- IPO date
- Feb 6, 2015
Earnings Waterfall
Poxel SA
The intrinsic value for Poxel SA (7PO) under the Base Case is hidden EUR.
Compared with the current market price of 0.185 EUR, the stock appears hidden.